TNF and acute myeloid leukemia: It has been hypothesized in several studies that malignant HSC from MPNs or leukemic initiating cells (LICs) in AML may harbor cell-autonomous mechanisms enabling these cells to further resist toxic or myelosuppressive effects of TNF acting on their non-malignant counterpart cells (53, 82, 96, 97).